Mark Shearman

2021

In 2021, Mark Shearman earned a total compensation of $3.5M as Executive Vice President and Chief Scientific Officer at Editas Medicine.

Compensation breakdown

Bonus$247,500
Non-Equity Incentive Plan$133,909
Option Awards$1,299,984
Salary$253,077
Stock Awards$1,609,963
Other$5,405
Total$3,549,838

Shearman received $1.6M in stock awards, accounting for 45% of the total pay in 2021.

Shearman also received $247.5K in bonus, $133.9K in non-equity incentive plan, $1.3M in option awards, $253.1K in salary and $5.4K in other compensation.

Rankings

In 2021, Mark Shearman's compensation ranked 3,760th out of 12,415 executives tracked by ExecPay. In other words, Shearman earned more than 69.7% of executives.

ClassificationRankingPercentile
All
3,760
out of 12,415
70th
Division
Manufacturing
1,534
out of 5,505
72nd
Major group
Chemicals And Allied Products
620
out of 2,375
74th
Industry group
Drugs
549
out of 2,096
74th
Industry
Biological Products, Except Diagnostic Substances
143
out of 449
68th

Pay ratio

Mark Shearman's Pay$3,549,838
Median Employee's Pay$181,354
Pay Ratio

20

to 1

In 2021, the annual total compensation of Mark Shearman was $3,549,838.

The annual total compensation of the median employee at Editas Medicine was $181,354.

The ratio of Mark Shearman's pay to the pay of median employee was therefore 20 to one.

Source: SEC filing on April 26, 2022.

Shearman's colleagues

We found five more compensation records of executives who worked with Mark Shearman at Editas Medicine in 2021.

2021

James Mullen

Editas Medicine

Chief Executive Officer

2021

Michelle Robertson

Editas Medicine

Chief Financial Officer

2021

Bruce Eaton

Editas Medicine

Executive Vice President and Chief Business Officer

2021

Lisa Michaels

Editas Medicine

Chief Medical Officer

2021

Cynthia Collins

Editas Medicine

Chief Executive Officer

News

You may also like